Table of Contents
Chapter One: Executive Summary
- Glycobiology
- Glycotherapeutics
- Potential Treatments and Products
- Market Summary
- Methodology
Chapter Two: Introduction
- Overview
- Role of Carbohydrates
- Structures
- Complex Carbohydrates
- Role of Sugars
- Impact on Health
- Clinical Activity
- Protein Drugs
- Small Molecule Drugs
- Promising Research
- Muscular Dystrophy
- Alternative Glycosylated Painkiller
- New Synthesis Strategy
- Manufacturing with Bacteria
- Insulin Resistance
Chapter Three: Markets
- Glycobiology Segment
- Glycosylated Protein Segment
- Market Forecasts
Chapter Four: Corporate Profiles
- Alchemia
- Associates of Cape Cod Inc.
- Consortium for Functional Glycomics
- GlycoFi Inc.
- GlycoGenesys Inc.
- GlycoMimetics Inc.
- Inflazyme Pharmaceuticals Ltd.
- Momenta Pharmaceuticals
- Neose Technologies Inc.
- ProtoKinetix Inc.
list of exhibits
- Exhibit 1: Advantages of Controlling Glycosylation
- Exhibit 2: World Market for Glycosylated Therapeutics 2005-2009
- Exhibit 3: Potential Uses for Carbohydrate Mimics
- Exhibit 4: World Market for Non-Glycosylated Proteins 2005-2009
- Exhibit 5: World Market for Glycosylated Proteins 2005-2009
- Exhibit 6: North American Market for Glycosylated Proteins 2005-2009
- Exhibit 7: European Market for Glycosylated Proteins 2005-2009
- Exhibit 8: Rest of World Market for Glycosylated Proteins 2005-2009
- Exhibit 9: Glycosylated Proteins Market Share by Geographic Region
|
Related Report
|
View Cart
